GUTS (Fractyl Health, Inc.) Stock Market Reviews

crown

search

Read and share opinions on GUTS (Fractyl Health, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

GUTS

Fractyl Health, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Fractyl Health Inc (GUTS) Q3 2025 Earnings Call Highlights: Pioneering Weight Loss Solutions ...
Nov 13, 2025
Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025
Nov 5, 2025
Fractyl Health Unveils Potent Preclinical Data for Dual GIP/GLP-1 Gene Therapy RJVA-002 for Obesity
Oct 17, 2025
Fractyl Health Announces Potent Preclinical Results from RJVA-002, a Dual GIP/GLP-1 Gene Therapy Candidate for Obesity
Oct 7, 2025
Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock
Sep 26, 2025
Fractyl Health Expands Board of Directors with Appointments of Industry Leaders to Advance Clinical Execution and Strategic Growth
Sep 3, 2025
Fractyl Health First Half 2025 Earnings: US$1.06 loss per share (vs US$0.57 loss in 1H 2024)
Aug 14, 2025
Fractyl Health Inc (GUTS) Q2 2025 Earnings Call Highlights: Financial Discipline and Promising ...
Aug 13, 2025
Fractyl Health Announces Closing of $23 Million Underwritten Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
Aug 7, 2025
Fractyl Health to Report Second Quarter 2025 Financial Results and Provide Business Updates on August 12, 2025, and Will Participate in an Upcoming Investor Conference
Aug 6, 2025
Fractyl Health Announces Pricing of $20 Million Underwritten Public Offering
Aug 6, 2025
Fractyl Health Announces Proposed Public Offering
Aug 5, 2025
Canaccord Genuity Reiterates Buy Rating on Fractyl Health (GUTS)
Jul 29, 2025
Fractyl Health Presents New Data at the American Diabetes Association’s 85th Scientific Sessions Demonstrating its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform Prevents Obesity and Type 2 Diabetes in Preclinical Models
Jun 23, 2025

Reviews